Durvalumab Plus Tremelimumab in Solid Tumors: A Systematic Review

Arru, C; De Miglio, MR; Cossu, A; Muroni, MR; Carru, C; Zinellu, A; Paliogiannis, P

De Miglio, MR (corresponding author), Univ Sassari, Dept Med Clin & Expt Sci, Viale San Pietro 43, I-07100 Sassari, Italy.

ADVANCES IN THERAPY, 2021; 38 (7): 3674

Abstract

Introduction Cancer immunotherapy represents one of the most important innovations in modern medicine. Durvalumab is an anti-programmed cell death lig......

Full Text Link